Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00685334 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa
A Phase 4 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT00685334 is a Phase 4 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 22 participants.
The verdict
NCT00685334, a Phase 4 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study will compare the effectiveness of two atypical antipsychotic medications, olanzapine and aripiprazole, in treating people with anorexia nervosa.
Interventions
- DRUG Olanzapine
- DRUG Aripiprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2003-11 |
| Est. Completion | 2006-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00685334
The ClinicalTrials.gov registry entry for NCT00685334 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Olanzapine is the first listed.
NCT00685334 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00685334 about?
NCT00685334 is a clinical study titled "Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa". This study will compare the effectiveness of two atypical antipsychotic medications, olanzapine and aripiprazole, in treating people with anorexia nervosa.
What is the current status of trial NCT00685334?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2003-11. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00685334?
The interventions under investigation include: Olanzapine (DRUG), Aripiprazole (DRUG).
Who is sponsoring clinical trial NCT00685334?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.